Cargando…

Twelve-week, prospective, open-label, randomized trial on the effects of an anticholinergic agent or antidiuretic agent as add-on therapy to an alpha-blocker for lower urinary tract symptoms

PURPOSE: The effects of an anticholinergic or antidiuretic agent as add-on therapy to an alpha-blocker for lower urinary tract symptoms (LUTS) according to a voiding diary in 3 days are unknown. We prospectively investigated the efficacy of an anticholinergic or antidiuretic agent as add-on therapy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shin, Yu Seob, Zhang, Li Tao, Zhao, Chen, Kim, Young Gon, Park, Jong Kwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099105/ https://www.ncbi.nlm.nih.gov/pubmed/25031529 http://dx.doi.org/10.2147/CIA.S64194

Ejemplares similares

Comparative Effectiveness of Anticholinergic Agents for Lower Urinary Tract Symptoms
por: Goodson, Ali B., et al.
Publicado: (2018)

Efficacy and Safety of Initial Combination Treatment of an Alpha Blocker with an Anticholinergic Medication in Benign Prostatic Hyperplasia Patients with Lower Urinary Tract Symptoms: Updated Meta-Analysis
por: Kim, Hyun Jung, et al.
Publicado: (2017)

Add-on anticholinergic therapy for residual nocturia in patients with lower urinary tract symptoms receiving α1-blocker treatment: a multi-centre, prospective, randomised study
por: Yokoyama, Osamu, et al.
Publicado: (2014)

Alpha-Blocker Treatment Response in Men With Lower Urinary Tract Symptoms Based on Sympathetic Activity: Prospective, Multicenter, Open-Labeled, Observational Study
por: Park, Sung Gon, et al.
Publicado: (2015)

Anticholinergic Agents Can Induce Oromandibular Dyskinesia
por: Shin, Hee-Young, et al.
Publicado: (2009)

Neuroleptic Malignant Syndrome Improved with Intramuscular Administration of the Anticholinergic Agent, Biperiden
por: Nisijima, Koichi
Publicado: (2023)

Urinary reabsorption in the rat kidney by anticholinergics
por: Oe, Hideki, et al.
Publicado: (2021)

Changes in autonomic nervous system activity after treatment with alpha-blocker in men with lower urinary tract symptoms
por: Shim, Kang Hee, et al.
Publicado: (2018)

Prescription pattern of alpha-blockers for management of lower urinary tract symptoms/benign prostatic hyperplasia
por: Moon, Hyong Woo, et al.
Publicado: (2018)

Stent Position Is More Important than α-Blockers or Anticholinergics for Stent-Related Lower Urinary Tract Symptoms after Ureteroscopic Ureterolithotomy: A Prospective Randomized Study
por: Lee, Sun Ju, et al.
Publicado: (2010)

Desmopressin plus anticholinergic agent in the treatment of nocturnal enuresis: A meta-analysis
por: Yu, Jianyong, et al.
Publicado: (2017)

Changes in attention variables in those who treated with anticholinergic agents for nonmonosymptomatic enuresis
por: Jang, Gwan, et al.
Publicado: (2020)

Comparison of reversal and adverse effects of sugammadex and combination of — Anticholinergic-Anticholinesterase agents in pediatric patients
por: Özgün, Çiğdem, et al.
Publicado: (2014)

Bladder Wall Thickness is Associated with Responsiveness of Storage Symptoms to Alpha-Blockers in Men with Lower Urinary Tract Symptoms
por: Park, Jung Soo, et al.
Publicado: (2012)

Discontinuation of alpha-blocker therapy in men with lower urinary tract symptoms: a systematic review and meta-analysis
por: van der Worp, Henk, et al.
Publicado: (2019)

Streptococcus mitis: An Unusual Causative Agent for Urinary Tract Infection
por: Swain, Bichitrananda, et al.
Publicado: (2013)

Effects of anticholinergic agent on miRNA profiles and transcriptomes in a murine model of allergic rhinitis
por: Hou, Minghua, et al.
Publicado: (2017)

Desmopressin in combination with anticholinergic agents in the treatment of nocturnal enuresis: a systematic review and meta-analysis
por: Cai, Tong, et al.
Publicado: (2023)

Effect of the symptom-based alpha-blocker treatment on lower urinary tract symptoms in women: systematic review and meta-analysis
por: Kang, Tae Wook, et al.
Publicado: (2021)

Alkalising agents in urinary tract infections: theoretical contraindications, interactions and synergy
por: Kavanagh, Oisín N.
Publicado: (2022)

Disseminated tuberculosis infection and paradoxical reaction during antimycobacterial treatment related to TNF-alpha blocker agent Infliximab
por: Unlu, Mehmet, et al.
Publicado: (2014)

Alpha-1 Adrenergic Receptor Blockers for the Treatment of Lower Urinary Tract Symptoms in Women: A Systematic Review and Meta-Analysis
por: Kim, Do Kyung, et al.
Publicado: (2019)

An integrative review of standardized clinical evaluation tool utilization in anticholinergic drug trials for neurogenic lower urinary tract dysfunction
por: Stothers, L, et al.
Publicado: (2016)

β-blockers: a novel class of antitumor agents
por: Ji, Yi, et al.
Publicado: (2012)

Empiric Usage of “Anti-Pseudomonal” Agents for Hospital-Acquired Urinary Tract Infections
por: Rahat, Ori, et al.
Publicado: (2022)

Predictive factors for alpha blocker use after transurethral prostatectomy: Can preoperative urodynamic outcome predict alpha blocker medication after surgery?
por: Kim, Sung Jin, et al.
Publicado: (2022)

Adenosine modulators and calcium channel blockers as add-on treatment for schizophrenia
por: Lintunen, Jonne, et al.
Publicado: (2021)

A comparative study of alpha-1a blockers (tamsulosin) versus estrogens in the treatment of lower urinary tract symptoms in perimenopausal females
por: Maiti, Krishnendu, et al.
Publicado: (2020)

The Efficacy and Safety of Propiverine Hydrochloride in Patients with Overactive Bladder Symptoms Who Poorly Responded to Previous Anticholinergic Agents
por: Masumori, Naoya, et al.
Publicado: (2011)

Rationale for the Use of Anticholinergic Agents in Overactive Bladder With Regard to Central Nervous System and Cardiovascular System Side Effects
por: Çetinel, Bülent, et al.
Publicado: (2013)

Increased risk of incident dementia following use of anticholinergic agents: A systematic literature review and meta‐analysis
por: Dmochowski, Roger R., et al.
Publicado: (2020)

Symptom improvement and predictors associated with improvement after 6 weeks of alpha-blocker therapy: An exploratory, single-arm, open-label cohort study
por: van der Worp, Henk, et al.
Publicado: (2019)

Efficacy and safety of muscarinic antagonists as add-on therapy for male lower urinary tract symptoms
por: Li, Jinhong, et al.
Publicado: (2014)

Angiotensin receptor blocker add-on therapy in portal hypertension: To use angiotensin receptor blocker or not to use, that is the question
por: Lee, Hyun Woong
Publicado: (2014)

Alpha–blocker and apoptosis
por: Elterman, Dean S., et al.
Publicado: (2013)

AB072. Antimicrobial agents for preventing urinary tract infections in patients undergoing cystoscopy
por: Zeng, Shuxiong, et al.
Publicado: (2018)

1415. Allergies to Antimicrobial Agents Among US Females with Uncomplicated Urinary Tract Infection
por: Thompson, Jeffrey, et al.
Publicado: (2021)

Response to “A comparative study of alpha-1a blockers (tamsulosin) versus estrogens in the treatment of lower urinary tract symptoms in perimenopausal females”
por: Patil, Anant
Publicado: (2020)

Trospium chloride: an update on a quaternary anticholinergic for treatment of urge urinary incontinence
por: Guay, David RP
Publicado: (2005)

Seminal papers in urology: anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence
por: Shugg, Nathan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s6rphj59lgpvf2bv3qftet3rn2